NCT05324982View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics of CHI-914 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Behavioral Pharmacology of Cannabis
Interventions
DRUG

Oral Placebo

Placebo will be orally self-administered by study participants.

DRUG

Oral CBG Cannabis

CBG cannabis oil will be orally self-administered by study participants.

Trial Locations (1)

21224

RECRUITING

Behavioral Pharmacology Research Unit, Baltimore

All Listed Sponsors
collaborator

Canopy Growth Corporation

INDUSTRY

lead

Johns Hopkins University

OTHER